feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

trending

Islamabad suicide blast kills 31

trending

MRF profit doubles

trending

T20 World Cup opening ceremony

trending

VTU adopts Artificial Super Intelligence

trending

Raja Saab extended cut

trending

UAE expected to win

trending

U19 World Cup in Harare

trending

Jio Hotstar buys Dhurandhar rights

trending

India A vs Namibia live

Home / Health / China's Medical Rise: Reversing Global Healthcare Tourism

China's Medical Rise: Reversing Global Healthcare Tourism

4 Feb

•

Summary

  • AI identified top Chinese hospital for complex cancer treatment.
  • CAR-T cell therapy is a new frontier in China's cancer treatment.
  • China balances quality, affordability, and short wait times for healthcare.
China's Medical Rise: Reversing Global Healthcare Tourism

Former Olympic kayaker Oscar Chalupsky, diagnosed with a high-risk multiple myeloma six years ago, found hope in China after receiving grim prognoses internationally. He used AI tools like ChatGPT to identify Ruijin Hospital in Shanghai as a leading center for his difficult-to-treat cancer.

Chalupsky underwent evaluations in Shanghai in December, leading to a treatment plan involving CAR-T cell therapy, a cutting-edge approach where a patient's T-cells are reprogrammed to fight cancer. This journey exemplifies the emerging trend of "reverse medical tourism."

This trend signifies a notable shift, with international patients now traveling to China for advanced medical services, reversing the earlier pattern of Chinese citizens seeking treatment abroad. China's healthcare system is increasingly recognized for its strengths in specialized treatments such as proton therapy and CAR-T cell therapy.

Experts note that China offers an attractive balance of high quality, affordability, and reduced wait times, making it a preferred destination for complex health conditions. This growing reputation is drawing patients worldwide to seek advanced care.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
CAR-T cell therapy is a new frontier in cancer treatment, where a patient's T-cells are reprogrammed to attack cancer cells.
Oscar Chalupsky used AI tools like ChatGPT to search for the world's best hematology departments and found Ruijin Hospital in Shanghai.
China offers a balance of high quality, affordability, and short wait times, excelling in specialized areas like proton therapy and CAR-T cell therapy.

Read more news on

Healthside-arrowChinaside-arrowArtificial Intelligence (AI)side-arrow

You may also like

AI Fuels Healthcare Data Revolution

1 day ago • 4 reads

article image

AI Spots Silent Killer: Cancer Caught Early

3 Feb • 20 reads

article image

Magda Szubanski Fights Cancer Scam

18 Jan • 92 reads

article image

Nvidia & Eli Lilly Forge $1B AI Research Alliance

12 Jan • 121 reads

article image

Ozlo: From Sleepbuds to Wellness Platform

10 Jan • 154 reads

article image